Table 1.
Model | Inducer/Method | Animal/Cell | Effects | Mechanisms | Reference |
---|---|---|---|---|---|
Cerebral ischemia, pseudo-germ-free | MCAO, Intragastrical administration of neomycin sulfate combined with streptomycin | Sprague-Dawley rats | ↓IL-1β, IL-6, TNF-α | Regulation of Lactobacillus helveticus abundance and GABAA receptor | [16] |
Cerebral ischemia | Middle cerebral artery occlusion (MCAO) | C57BL/6 J mice | ↓NADPH, ROS, NOX-1; ↑GSH | ↓ERK | [22] |
Cerebral ischemia/reperfusion | MCAO | C57BL/6 mice | Axonal regeneration | ↑cAMP/PKA/CREB | [15] |
Cerebral ischemia/reperfusion | MCAO | Sprague-Dawley rats | ↓Infarct size, Neurological deficit scores; Blood Brain Barrier (BBB) permeability | ↓Cx43, AQP4 (cerebral) | [13] |
Traumatic Brain Injury | Craniotomy | Wistar rats | ↓Brain infarct volume, Brain edema, Neuronal deficit | ↓ERK1/2, Cx40 | [14] |
Cerebral ischemia/reperfusion | MCAO | Wistar rats | ↓Infarct size, Caspase-3, Caspase-9, TNF-α, IL-6, NO, iNOS | ↓HMGB1, NF-κB | [23] |
Abnormal hippocampal microenvironment | Microperfusion of L-Glu and Ca2+ in the rat hippocampus | Sprague-Dawley rats | ↓Glu, Cyt-C; Increased the regional cerebral blood flow and the stability of neuronal ultrastructure in the hippocampal CA1 region and improved the adaptability of neurons | ↑GLT-1, ↓NMDAR | [21] |
Artificial Abnormal Hippocampal Microenvironment | Microperfusion of L-Glu and Ca2+ in the rat hippocampus | Sprague-Dawley rats | Alleviated Memory Deficit; Morphological Changes in Hippocampus | ↑P-Akt/P-mTOR; ↓P-PTEN | [20] |
Abbreviations are as shown in the literature. (↓), down-regulation or inhibition; (↑), up-regulation or activation.